Kyowa Kirin Co., Ltd. (TYO:4151)
2,399.50
+11.50 (0.48%)
May 26, 2026, 1:04 PM JST
Kyowa Kirin Revenue
Kyowa Kirin had revenue of 118.47B JPY in the quarter ending March 31, 2026, with 13.12% growth. This brings the company's revenue in the last twelve months to 510.57B, up 3.20% year-over-year. In the year 2025, Kyowa Kirin had annual revenue of 496.83B with 0.26% growth.
Revenue (ttm)
510.57B
Revenue Growth
+3.20%
P/S Ratio
2.45
Revenue / Employee
98.93M
Employees
5,161
Market Cap
1.25T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 496.83B | 1.27B | 0.26% |
| Dec 31, 2024 | 495.56B | 53.33B | 12.06% |
| Dec 31, 2023 | 442.23B | 43.86B | 11.01% |
| Dec 31, 2022 | 398.37B | 46.13B | 13.09% |
| Dec 31, 2021 | 352.25B | 33.89B | 10.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Otsuka Holdings | 2.52T |
| Astellas Pharma | 2.14T |
| Daiichi Sankyo Company | 2.12T |
| Chugai Pharmaceutical | 1.29T |
| Ono Pharmaceutical | 515.79B |
| Santen Pharmaceutical | 291.62B |
| JCR Pharmaceuticals | 40.32B |
| Perseus Proteomics | 135.00M |
Kyowa Kirin News
- 13 days ago - Kura, Kyowa Kirin to present updated frontline data from Phase 1 KOMET-007 trial - TheFly
- 18 days ago - Kyowa Kirin Quarterly report: Q1 2026 - Filings
- 18 days ago - Kyowa Kirin Slides: Q1 2026 - Filings
- 18 days ago - Kyowa Kirin Quarterly report: Q1 2026 - Filings
- 18 days ago - Kyowa Kirin Slides: Q1 2026 - Filings
- 18 days ago - Kyowa Kirin Quarterly report: Q1 2026 - Filings
- 18 days ago - Kyowa Kirin Slides: Q1 2026 - Filings
- 2 months ago - Kyowa Kirin downgraded to Sell from Buy at Citi - TheFly